4.8 Article

Simultaneous electrochemical immunoassay using CdS/DNA and PbS/DNA nanochains as labels

Journal

BIOSENSORS & BIOELECTRONICS
Volume 39, Issue 1, Pages 177-182

Publisher

ELSEVIER ADVANCED TECHNOLOGY
DOI: 10.1016/j.bios.2012.07.023

Keywords

CdS/DNA; PbS/DNA; Electrochemical immunoassay; Simultaneous detection; Square wave voltammetry

Funding

  1. 973 Program [2012CB932600]
  2. National Natural Science Foundation [21025522, 21135003]
  3. National Natural Science Funds for Creative Research Groups of China [21121091]

Ask authors/readers for more resources

An electrochemical method for the simultaneous detection of two different tumor markers, carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP), in one-pot, using CdS/DNA and PbS/DNA nanochains as labels was developed. Herein, magnetic beads (MBs) as bimolecule immobilizing carriers, were used for co-immobilization of primary anti-CEA and anti-AFP antibodies. The distinguishable signal labels were synthesized by in situ growth of CdS and PbS nanoparticles on DNA chains, respectively, which were further employed to label the corresponding secondary antibodies. A sandwich-type immunoassay format was formed by the biorecognition of the antigens and corresponding antibodies. The assay was based on the peak currents of Cd2+ and Pb2+ dissolved from CdS and PbS nanoparticles by HNO3 using square wave stripping voltammetry. Experimental results show that the multiplexed electrochemical immunoassay has enabled the simultaneous monitoring of CEA and AFP in a single run with wide working ranges of 0.1- 100 ng mL(-1) for CEA and 0.5-200 ng mL(-1) for AFP. The detection limits reach to 3.3 pg mL(-1) for CEA and 7.8 pg mL(-1) for AFP. (C) 2012 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available